Debiopharm Group Investor
Debiopharm Group is a biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. They develop their products for global registration and maximum commercial potential for out-licensing to pharmaceutical partners for sales and marketing.
Investor Type:
Private Equity Funds
Technology:
Biomarker Discovery & Validation
Founded Date:
1979-01-01
Industry:
BioPharma AI
Employee Number:
251-500
Funding Status:
private
Number Of Exists:
5
Headquarters:
Lausanne,Vaud,Switzerland,Europe